Differential expression profile of lung squamous cell carcinoma (LSCC) and druggable targets to be combined with necitumumab (N)
2016 ◽
Vol 11
(4)
◽
pp. S85-S86
◽
2015 ◽
Vol 47
(7)
◽
pp. 557-563
◽
2021 ◽
2019 ◽
2018 ◽
Vol 10
(4)
◽
pp. 836-847
◽
2015 ◽
Vol 14
(3)
◽
pp. 10185-10192
◽